within Pharmacolibrary.Drugs.ATC.G;

model G03AA15
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.88,
    Cl             = 1.2 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 2 / 1000000,
    adminCount     = 1,
    Vd             = 0.033,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.018333333333333333,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Combined oral contraceptive containing chlormadinone acetate, a progestin, and ethinylestradiol, an estrogen. Previously approved for contraception and hormonal regulation in women. Use is discontinued or rarely approved in most countries due to newer alternatives.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are for healthy premenopausal women following oral administration of combined fixed-dose tablet containing 2 mg chlormadinone acetate and 0.03 mg ethinylestradiol.</p><h4>References</h4><ol><li><p>Curran, MP, &amp; Wagstaff, AJ (2004). Ethinylestradiol/chlormadinone acetate. <i>Drugs</i> 64(7) 751–762. DOI:<a href=&quot;https://doi.org/10.2165/00003495-200464070-00005&quot;>10.2165/00003495-200464070-00005</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15025547/&quot;>https://pubmed.ncbi.nlm.nih.gov/15025547</a></p></li><li><p>Terlinden, R, et al., &amp; Kneip, C (2006). Pharmacokinetics of chlormadinone acetate following single and multiple oral dosing of chlormadinone acetate (2 mg) and ethinylestradiol (0.03 mg) and elimination and clearance of a single dose of radiolabeled chlormadinone acetate. <i>Contraception</i> 74(3) 239–244. DOI:<a href=&quot;https://doi.org/10.1016/j.contraception.2006.03.011&quot;>10.1016/j.contraception.2006.03.011</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/16904418/&quot;>https://pubmed.ncbi.nlm.nih.gov/16904418</a></p></li><li><p>Kuhl, H (1990). Pharmacokinetics of oestrogens and progestogens. <i>Maturitas</i> 12(3) 171–197. DOI:<a href=&quot;https://doi.org/10.1016/0378-5122(90)90003-o&quot;>10.1016/0378-5122(90)90003-o</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2170822/&quot;>https://pubmed.ncbi.nlm.nih.gov/2170822</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end G03AA15;
